Astera Labs, Inc. research snapshot
ALAB AI stock analysis as of the August 2, 2026 data cutoff reads Astera Labs as a fast-growing AI connectivity company that sold off hard in July and is now repricing. At the July 31, 2026 close, ALAB traded at $311.23, market capitalization was verified near $53.35 billion as $311.23 times 171.41 million shares with a 0.00% deviation, and the company reports Q2 2026 results on August 4, 2026. Q1 2026 revenue rose 93 percent year over year to $308.4 million, cross-validated against SEC EDGAR XBRL, the earnings release, and the call, with GAAP net income of $80.3 million and about $1.18 billion of cash and marketable securities on the balance sheet. Management guided Q2 2026 revenue to $355 million to $365 million and non-GAAP EPS to $0.68 to $0.70. The stock still trades at premium multiples, near 89x forward earnings and 53x sales, and the July move shows how fast the multiple can compress. This page is informational research only and is not investment advice.
Current price
$311.23
Market cap
$53.35 billion
AI score
68 / 100
Rating
High-growth AI connectivity leader at a still-demanding valuation after a sharp July correction
Trend status
Mixed trend: price above the 100-day and 200-day moving averages but below the 20-day and 50-day averages after a volatile July
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Astera Labs sells semiconductor-based connectivity products and software that move data across AI servers, accelerators, memory, switches, cables, and cloud infrastructure. TTM revenue reached about $1.00 billion, up 104 percent. | High |
| Moat | The moat comes from purpose-built mixed-signal IP, PCIe, CXL, Ethernet, and fabric expertise, COSMOS software telemetry, hyperscaler design wins, validation cycles, and early leadership in PCIe Gen 6 and Scorpio switching. It is not yet proven across a full semiconductor cycle. | Medium-high |
| Management | CEO Jitendra Mohan, COO Sanjay Gajendra, and new CFO Desmond Lynch have scaled revenue and earnings rapidly while expanding into Scorpio switches, optical technology, custom solutions, and new regions. The test is whether reinvestment converts into broad customer adoption without margin compression. | Medium-high |
| Financial trend | FY2025 revenue was $852.5 million, up 115 percent, with GAAP net income of $219.1 million. Q1 2026 revenue reached $308.4 million, up 93 percent, with 76.4 percent non-GAAP gross margin, 36.2 percent non-GAAP operating margin, and $0.61 non-GAAP EPS. | High |
| Valuation | At $311.23, financial_rigor.py calculated about 210x trailing EPS, 36x book value, 156x free cash flow per share, and 53x sales, with forward PE near 89x. The multiple is lower than in early July but still leaves little room for execution errors. | Medium-high |
| Technical trend | ALAB is in a mixed technical state after a volatile July. The stock closed at $311.23 on July 31, 2026, above the 100-day average near $259 and the 200-day near $208, but below the 20-day near $336 and the 50-day near $355, with 14-day RSI near 46. | Medium |
| Risk level | Risk is high because valuation is demanding, the stock is volatile with beta near 3.92, AI infrastructure demand can pause, large customers can pressure pricing, competitor products are well funded, and the stock has a short public record. The July drawdown from above $480 to near $245 shows the downside speed. | High |
| AI confidence | High for current reported data and filed financials that cross-validated across SEC EDGAR XBRL, the Q1 2026 earnings release and call, and StockAnalysis.com; medium for scenario analysis and technical setups ahead of the August 4 report. | High data confidence |
| Investment certainty | Medium-low certainty. ALAB may remain a category winner, but the current price still prices in strong growth and the July volatility shows that downside can arrive quickly when estimates or multiples reset. | Medium-low |
ALAB AI stock forecast
The ALAB AI stock forecast uses scenario ranges rather than a single price target. The framework, run with financial_rigor.py from the July 31, 2026 close of $311.23 and the FY2026 consensus non-GAAP EPS of about $3.02, produces a bullish area near $506, a base area near $299, and a bearish area near $106 over three years. These are scenarios, not promises, and the August 4, 2026 Q2 report is the next major checkpoint.
$470 to $540
More likely if non-GAAP EPS compounds near 40 to 45 percent for three years, investors keep paying a high-growth AI connectivity multiple, Scorpio X and P ramps broadly across multiple hyperscalers, PCIe Gen 6 and Taurus adoption stays strong, and gross margin holds in the low-to-mid 70 percent area.
$285 to $315
More likely if revenue growth remains strong but the multiple compresses toward a lower high-growth range. financial_rigor.py produced a base case near $299 using FY2026 consensus non-GAAP EPS of $3.02, 30 percent growth, and a 45x exit PE.
$95 to $120
More likely if AI infrastructure orders slow, customer concentration worsens, hyperscaler pricing pressure rises, margins reset lower, competition from Broadcom, Marvell, Credo, or in-house silicon intensifies, or the market stops valuing ALAB as a scarce AI connectivity asset. The July move toward $245 shows how quickly sentiment can turn.
ALAB AI technical analysis
ALAB AI technical analysis uses market data verified at the July 31, 2026 close, after a volatile July. StockAnalysis.com showed ALAB at $311.23, up 3.85 percent, after a 20 percent gain on July 30, with a 52-week range of $97.89 to $499.48 and beta near 3.92. Barchart and StockAnalysis.com both placed the 20-day moving average near $335.94, the 50-day near $355.21, the 100-day near $259.16, and the 200-day near $207.58. Because this static page does not fetch request-time chart data, every level should be refreshed in a live chart before trading.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $311.23 | StockAnalysis.com real-time quote at the July 31, 2026 close; market cap math uses 171.41 million shares outstanding. |
| Near support | $285 to $300 | A pullback zone near recent session lows and the round $300 area, where buyers defended the stock on July 30 before the rally to $311.23. |
| Deeper support | $244 to $260 | The July 29 intraday low near $244.61 and the 100-day moving average near $259.16 form the next downside reference if the rebound fails. |
| Major support | $205 to $210 | The 200-day moving average near $207.58 is the key long-term trend line. A sustained close below it would change the medium-term picture. |
| Near resistance | $335 to $342 | The 20-day moving average near $335.94 and the July 31 intraday high near $342.00 are the first upside levels to reclaim. |
| 50-day moving average | $355.21 | Barchart and StockAnalysis.com both reported the 50-day moving average near $355.21, a resistance zone after the July breakdown. |
| Major resistance | $499 to $500 | The June 30, 2026 52-week high near $499.48 is the major upper reference and remains far above the current price. |
| Momentum | RSI near 46, ADX near 26 | Barchart reported 14-day RSI near 46.33, neutral, with 14-day ADX near 26.47 and a slightly negative directional balance, showing the rebound has not yet confirmed a new uptrend. |
| Volume | About 5.3 million shares on July 31 | Barchart listed 20-day average volume near 4.4 million shares, and the July 31 session printed about 5.3 million shares, so follow-through volume matters for the rebound. |
| Volatility | Beta 3.92, extreme 14-day volatility | StockAnalysis.com reported beta near 3.92 and Barchart showed 14-day historical volatility near 112 percent, so position sizing should assume very large swings, especially around the August 4 earnings report. |
| Invalidation | Close below $260 | A decisive close below the $244 to $260 support zone would weaken the rebound and put the 200-day moving average near $208 under pressure. |
ALAB AI trading strategy
The ALAB AI trading strategy is a rules-based research framework for a volatile AI semiconductor stock. It is not personalized advice and should be paired with live chart data, the August 4, 2026 earnings report, position sizing, earnings dates, and a written invalidation rule.
Watch for ALAB to reclaim the $335 to $342 zone on rising volume, then confirm that the August 4 Q2 report, Scorpio shipment commentary, non-GAAP margin, and customer design wins support the move before adding exposure.
A failed reclaim or a close back below $300 should invalidate the short-term setup.
If ALAB pulls back toward the $285 to $300 zone without a negative earnings or customer-demand update, compare the move with Q2 guidance, market-cap math, volume, and semiconductor peer action before treating it as support.
Do not average down without a predefined maximum loss because beta near 3.92 and a premium valuation can create large gaps around earnings.
Track the August 4 Q2 2026 report, revenue guidance, Scorpio X and P ramp timing, PCIe Gen 6 and Taurus adoption, UALink and optical progress, customer concentration, stock-based compensation, cash flow, and Broadcom, Marvell, and Credo competitive signals.
Reduce confidence if revenue growth depends on a narrower customer base, gross margin falls below expectations, dilution outpaces buybacks, or valuation rises while forward EPS estimates stop increasing.
Investment research summary
Astera Labs is paid because AI and cloud data centers need reliable, low-latency connectivity between accelerators, memory, switches, cables, and software monitoring layers. Customers pay when connectivity limits system performance or deployment speed.
The moat is based on mixed-signal engineering, PCIe, CXL, Ethernet, and fabric protocol depth, COSMOS software, hyperscaler qualification, early PCIe Gen 6 and Scorpio leadership, and the cost of validating alternatives in mission-critical AI infrastructure.
The thesis fails if AI capex slows, custom silicon architectures reduce ALAB content, a large customer gains pricing leverage, competitors match the roadmap, stock-based compensation dilutes shareholders, or the market compresses the valuation faster than EPS compounds. The July move showed the compression speed.
Management has executed well since IPO, with rapid revenue growth, positive GAAP earnings, high gross margin, and a large cash position. The next scorecard is disciplined R&D, customer diversification, and durable cash flow through the Scorpio, optical, and custom solution cycles.
Rack-scale AI infrastructure is a strong long-term trend because accelerator clusters need more bandwidth, lower latency, better observability, and more reliable switching. The trend is attractive, but it can still produce cyclical inventory and valuation resets, as July 2026 showed.
The three-scenario model using FY2026 consensus non-GAAP EPS of $3.02 produced about $506 in the bull case, $299 in the base case, and $106 in the bear case. At $311.23, the price offers upside only if growth stays exceptional and the multiple stays elevated.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| ALAB price and market capitalization | $311.23 price, $53.35 billion verified market cap at the July 31, 2026 close | StockAnalysis.com quote and financial_rigor.py market cap verification | August 2, 2026 |
| Shares outstanding | 171.41 million shares, up 10.85 percent year over year | StockAnalysis.com share statistics and Q1 2026 Form 10-Q | August 2, 2026 |
| Q1 2026 revenue | $308.4 million, up 14 percent sequentially and 93 percent year over year, cross-validated across SEC EDGAR XBRL, the earnings release, and the call | Astera Labs Q1 2026 earnings release and Form 10-Q | August 2, 2026 |
| Q1 2026 GAAP net income | $80.3 million, cross-validated across SEC EDGAR XBRL and the earnings call | Astera Labs Q1 2026 Form 10-Q | August 2, 2026 |
| Q1 2026 non-GAAP results | 76.4 percent gross margin, 36.2 percent operating margin, and $0.61 diluted EPS on 181.2 million diluted shares | Astera Labs Q1 2026 earnings call | August 2, 2026 |
| Q1 2026 cash and marketable securities | $1.184 billion, flat versus Q4, cross-checked against SEC EDGAR XBRL and StockAnalysis.com | Astera Labs Q1 2026 Form 10-Q | August 2, 2026 |
| Q2 2026 outlook | Revenue guidance of $355 million to $365 million, up 15 to 18 percent sequentially, non-GAAP gross margin near 73 percent, and non-GAAP EPS of $0.68 to $0.70 | Astera Labs Q1 2026 earnings call | August 2, 2026 |
| FY2025 revenue and net income | $852.5 million revenue, up 115 percent, and $219.1 million GAAP net income, cross-checked across SEC EDGAR XBRL and StockAnalysis.com with 0.00% deviation | Astera Labs FY2025 Form 10-K and StockAnalysis.com | August 2, 2026 |
| TTM financials | TTM revenue about $1.001 billion, TTM net income $267.63 million, TTM EPS $1.48, gross margin 75.99 percent, operating margin 22.36 percent | StockAnalysis.com financial statements | August 2, 2026 |
| Balance sheet | Cash and short-term investments of $1.184 billion, total debt of $41.85 million, net cash near $1.14 billion or $6.67 per share, equity of $1.49 billion | StockAnalysis.com balance sheet | August 2, 2026 |
| Free cash flow | TTM operating cash flow of $383.40 million, capex of $40.59 million, and free cash flow of $342.81 million, with FY2025 free cash flow of $281.76 million | StockAnalysis.com cash flow statement | August 2, 2026 |
| Valuation ratios | About 210x trailing PE, 89x forward PE, 53x sales, 36x book value, 156x P/FCF, 1.77 PEG | StockAnalysis.com statistics and financial_rigor.py valuation verification | August 2, 2026 |
| Analyst consensus | Buy with an average target of $300.20 across 26 analysts, low $155 and high $475, median $275 | StockAnalysis.com forecast and analyst ratings | August 2, 2026 |
| Analyst rating mix, July 2026 | 11 Strong Buy, 7 Buy, 8 Hold, 0 Sell, 0 Strong Sell out of 26 analysts | StockAnalysis.com forecast recommendation trends | August 2, 2026 |
| Recent analyst target updates | Susquehanna $230 to $275, Citi $245 to $315, Barclays $200 to $325, TD Cowen $225 to $425, UBS $205 to $400, Stifel $260 to $460, BofA $240 to $450 | StockAnalysis.com forecast latest forecasts, TipRanks | August 2, 2026 |
| Consensus estimates | FY2026 revenue estimate about $1.55B with non-GAAP EPS of $3.02, FY2027 revenue about $2.24B with non-GAAP EPS of $4.56 | StockAnalysis.com forecast financial forecast | August 2, 2026 |
| Short interest | 9.53 million shares short, 5.56 percent of shares outstanding, 1.59 days to cover | StockAnalysis.com statistics short selling | August 2, 2026 |
| Product and roadmap commentary | Scorpio was about 15 percent of FY2025 revenue and is expected to become the largest product line by the end of 2026; PCIe Gen 6 was more than one-third of Q1 revenue; content per accelerator is above $1,000; UALink fabric, CXL KV cache, and optical NPO and CPO are the next growth vectors | Astera Labs Q1 2026 earnings call and June 2026 Evercore conference | August 2, 2026 |
| Technical range | July 31 close $311.23, day range $305.00 to $342.00, 52-week range $97.89 to $499.48, beta 3.92, RSI near 46, 20-day average near $335.94, 50-day near $355.21, 100-day near $259.16, 200-day near $207.58 | StockAnalysis.com and Barchart technical snapshots | August 2, 2026 |
This ALAB AI stock analysis page is an informational research tool. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast scenarios are based on available public data at the cutoff date, may be wrong, and should be checked against fresh filings, market data, and your own risk limits.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
